Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Exp Neurol ; 318: 244-250, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-31078524

RESUMEN

Hemopexin (Hpx) is critical for hemin scavenging after the erythrocyte lysis that occurs following intracerebral hemorrhage (ICH). Low-density lipoprotein receptor-related protein-1 (LRP1, also called CD91) is an important receptor through which the hemin-Hpx complex can undergo endocytosis. This study investigated changes in the hemin-Hpx-CD91 axis in both hematoma and perihematomal tissue in a large animal ICH model. The effect of deferoxamine (DFX) on hemin-Hpx-CD91 was also examined. The study consisted of two parts. First, piglets had an injection of autologous blood into the right frontal lobe of brain and were euthanized from day 1 to day 7. Hematoma and perihematomal tissue of brains were used for hemin assay, immunohistochemistry, and immunofluorescence. Second, piglets with ICH were treated with deferoxamine or vehicle, and were euthanized for hemin measurement and Hpx and CD91 immunohistochemistry. We found that there was an increase of hemin levels within the hematoma and perihematomal brain tissue after ICH. Hpx and CD91-positive cells were present in the clot and perihematomal tissue from day 1. Hpx and CD91 positive cells were Iba1 positive. After DFX therapy, hemin dropped markedly in the hematoma and perihematomal brain tissue. Furthermore, DFX treatment decreased the number of Hpx and CD91 positive cells in and around the hematoma. In conclusion, hemin accumulation occurs in and around the hematoma. Increases in Hpx and CD91 may be important in scavenging that hemin. DFX treatment decreased hemin release from the hematoma and reduced the expression of Hpx and CD91.


Asunto(s)
Hemorragia Cerebral/patología , Deferoxamina/farmacología , Hemina/metabolismo , Sideróforos/farmacología , Animales , Hemorragia Cerebral/metabolismo , Hemopexina/efectos de los fármacos , Hemopexina/metabolismo , Proteína 1 Relacionada con Receptor de Lipoproteína de Baja Densidad/efectos de los fármacos , Proteína 1 Relacionada con Receptor de Lipoproteína de Baja Densidad/metabolismo , Masculino , Porcinos
2.
Stroke ; 49(12): 3020-3029, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30571407

RESUMEN

Background and Purpose- Heme and iron are considered to be key factors responsible for secondary insults after intracerebral hemorrhage (ICH). Our previous study showed that LRP1 (low-density lipoprotein receptor-related protein-1)-Hx (hemopexin) facilitates removal of heme. The TLR7 (Toll-like receptor 7)-BTK (Bruton tyrosine kinase)-CRT (calreticulin) pathway regulates the expression of LRP1-Hx. This study is designed to clarify whether TLR7 activation facilitates heme scavenging and to establish the potential role of the BTK-CRT-LRP1-Hx signaling pathway in the pathophysiology of ICH. Methods- ICH was induced by stereotactic, intrastriatal injection of type VII collagenase. Mice received TLR7 agonist (imiquimod) via intraperitoneal injection after ICH induction. TLR7 inhibitor (ODN2088), BTK inhibitor (LFM-A13), and CRT agonist (thapsigargin) were given in different groups to further evaluate the underlying pathway. Mice were randomly divided into sham, ICH+vehicle (normal saline), ICH+Imiquimod (2.5, 5, and 10 µg/g), ICH+ODN2088, ICH+LFM-A13, ICH+thapsigargin, and ICH+ODN2088+thapsigargin. Imiquimod was administered twice daily starting at 6 hours after ICH; ODN2088 was administered by intracerebroventricular injection at 30 minutes, and LFM-A13 or thapsigargin was administered by intraperitoneal injection at 3 hours after ICH induction. Neurological scores, cognitive abilities, as well as brain edema, blood-brain barrier permeability, hemoglobin level, brain expression of TLR7/BTK/CRT/LRP1/Hx were analyzed. Results- Low dosage imiquimod significantly attenuated hematoma volume, brain edema, BBB permeability, and neurological deficits after ICH. Imiquimod also increased protein expressions of TLR7, BTK, CRT, LRP1, and Hx; ODN2088 reduced TLR7, BTK, CRT, LRP1, and Hx expressions. Conclusions- TLR7 plays an important role in heme scavenging after ICH by modulating the BTK-CRT-LRP1-Hx pathway. TLR7 may offer protective effects by promoting heme resolution and reduction of brain edema after ICH.


Asunto(s)
Agammaglobulinemia Tirosina Quinasa/metabolismo , Encéfalo/metabolismo , Calreticulina/metabolismo , Hemorragia Cerebral/metabolismo , Hemo/metabolismo , Hemopexina/metabolismo , Glicoproteínas de Membrana/metabolismo , Receptores de LDL/metabolismo , Receptor Toll-Like 7/metabolismo , Proteínas Supresoras de Tumor/metabolismo , Agammaglobulinemia Tirosina Quinasa/antagonistas & inhibidores , Agammaglobulinemia Tirosina Quinasa/efectos de los fármacos , Amidas/farmacología , Animales , Barrera Hematoencefálica/efectos de los fármacos , Encéfalo/efectos de los fármacos , Edema Encefálico/metabolismo , Calreticulina/agonistas , Calreticulina/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Hemopexina/efectos de los fármacos , Imiquimod/farmacología , Proteína 1 Relacionada con Receptor de Lipoproteína de Baja Densidad , Glicoproteínas de Membrana/agonistas , Glicoproteínas de Membrana/antagonistas & inhibidores , Glicoproteínas de Membrana/efectos de los fármacos , Ratones , Nitrilos/farmacología , Oligodesoxirribonucleótidos/farmacología , Receptores de LDL/efectos de los fármacos , Transducción de Señal , Tapsigargina/farmacología , Receptor Toll-Like 7/agonistas , Receptor Toll-Like 7/antagonistas & inhibidores , Receptor Toll-Like 7/efectos de los fármacos , Proteínas Supresoras de Tumor/efectos de los fármacos
3.
J Biol Chem ; 285(27): 20499-506, 2010 Jul 02.
Artículo en Inglés | MEDLINE | ID: mdl-20430887

RESUMEN

The stability of the hemopexin-heme (Hx-heme) complex to dissociation of the heme prosthetic group has been examined in bicarbonate buffers in the presence and absence of various divalent metal ions. In NH(4)HCO(3) buffer (pH 7.4, 20 mm, 25 degrees C) containing Zn(2+) (100 microm), 14% of the heme dissociates from this complex (4.5 microm) within 10 min, and 50% dissociates within 2 h. In the absence of metal ions, the rate of dissociation of this complex is far lower, is decreased further in KHCO(3) solution, and is minimal in NaHCO(3). In NH(4)HCO(3) buffer, dissociation of the Hx-heme complex is accelerated by addition of divalent metals with decreasing efficiency in the order Zn(2+) > Cu(2+) >> Ni(2+) > Co(2+)>>Mn(2+). Addition of Ca(2+) prior to addition of Zn(2+) stabilizes the Hx-heme complex to dissociation of the heme group, and addition of Ca(2+) after Zn(2+)-induced dissociation of the Hx-heme complex results in re-formation of the Hx-heme complex. These effects are greatly accelerated at 37 degrees C and diminished in other buffers. Overall, the solution conditions that promote formation of the Hx-heme complex are similar to those found in blood plasma, and conditions that promote release of heme are similar to those that the Hx-heme complex should encounter in endosomes following endocytosis of the complex formed with its hepatic receptor.


Asunto(s)
Electrólitos/farmacología , Hemo/metabolismo , Hemopexina/metabolismo , Metales/farmacología , Bicarbonatos/farmacología , Hemopexina/efectos de los fármacos , Humanos , Concentración de Iones de Hidrógeno , Cinética , Compuestos de Potasio/farmacología , Bicarbonato de Sodio/farmacología , Espectrofotometría , Espectrofotometría Ultravioleta
4.
Arch Ital Biol ; 140(2): 91-100, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12004646

RESUMEN

The effect of K and Mg salts of aspartic acid (Cardilan) on the serum concentration of selected proteins and phagocytic activity in aging male Wistar rats was investigated. Cardilan was administered in tap water for 7 days a month for 3 months before the last observed interval (12, 18 and 24 month). In a part of animals, the aging process was accelerated by sublethally gamma-irradiation. The administration of Cardilan slowed down the changes in the concentration of prealbumin, albumin, haptoglobin, haemopexin, C3 complement in non-irradiated rats (DC). This effect was extended to the changes in transferrin level in irradiated rats (IDC). The phagocytic activity in both DC, IDC rats was lower compared with controls drinking water (DW, IDW), but not significantly. The effect of Cardilan administration appears to be the greatest in 24-month-old rats, when the treated animals survived better by 25% in IDC group and by 26% better in DC rats, compared with those of the same age controls. Potassium and magnesium salts of aspartates are suitable compounds for life prolongation in the experimental conditions.


Asunto(s)
Envejecimiento/efectos de los fármacos , Ácido Aspártico/farmacología , Proteínas Sanguíneas/efectos de los fármacos , Envejecimiento/metabolismo , Envejecimiento/efectos de la radiación , Animales , Proteínas Sanguíneas/metabolismo , Proteínas Sanguíneas/efectos de la radiación , Complemento C3/efectos de los fármacos , Complemento C3/metabolismo , Complemento C3/efectos de la radiación , Rayos gamma/efectos adversos , Haptoglobinas/efectos de los fármacos , Haptoglobinas/metabolismo , Haptoglobinas/efectos de la radiación , Hemopexina/efectos de los fármacos , Hemopexina/metabolismo , Hemopexina/efectos de la radiación , Inmunidad Innata/efectos de los fármacos , Inmunidad Innata/inmunología , Inmunidad Innata/efectos de la radiación , Masculino , Neutrófilos/efectos de los fármacos , Neutrófilos/metabolismo , Neutrófilos/efectos de la radiación , Fagocitosis/efectos de los fármacos , Fagocitosis/inmunología , Fagocitosis/efectos de la radiación , Ratas , Ratas Wistar , Albúmina Sérica/efectos de los fármacos , Albúmina Sérica/metabolismo , Albúmina Sérica/efectos de la radiación , Tasa de Supervivencia , Transferrina/efectos de los fármacos , Transferrina/metabolismo , Transferrina/efectos de la radiación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA